HCA Healthcare Reports Strong Q2 Earnings, Revenue Rise
HCA Healthcare reported Q2 revenue of $20.23 billion, up 8.7% year over year, with net income of $1.699 billion and diluted EPS of $7.62, while adjusted EBITDA rose to $4.027 billion and the company kept its 2026 EPS guidance at $28.70–$30.50 as it cited higher uninsured volumes and lower surgical activity; the stock rose about 1.3%. Analysts pared their targets after softer Q2 results and guidance, with Wells Fargo trimming to $369 and Barclays to $402, while noting a need for stronger organic growth later in 2026.